HK1144102A1 - Rnai modulation of rsv and therapeutic uses thereof rsv - Google Patents

Rnai modulation of rsv and therapeutic uses thereof rsv

Info

Publication number
HK1144102A1
HK1144102A1 HK10110495.7A HK10110495A HK1144102A1 HK 1144102 A1 HK1144102 A1 HK 1144102A1 HK 10110495 A HK10110495 A HK 10110495A HK 1144102 A1 HK1144102 A1 HK 1144102A1
Authority
HK
Hong Kong
Prior art keywords
rsv
therapeutic uses
rnai modulation
rnai
modulation
Prior art date
Application number
HK10110495.7A
Inventor
Rachel Meyers
Original Assignee
Alnylam Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alnylam Pharmaceuticals Inc filed Critical Alnylam Pharmaceuticals Inc
Publication of HK1144102A1 publication Critical patent/HK1144102A1/en

Links

HK10110495.7A 2005-01-07 2008-02-25 Rnai modulation of rsv and therapeutic uses thereof rsv HK1144102A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64236405P 2005-01-07 2005-01-07
US65982805P 2005-03-09 2005-03-09
HK08102068 2008-02-25

Publications (1)

Publication Number Publication Date
HK1144102A1 true HK1144102A1 (en) 2011-01-28

Family

ID=47290416

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10110495.7A HK1144102A1 (en) 2005-01-07 2008-02-25 Rnai modulation of rsv and therapeutic uses thereof rsv

Country Status (1)

Country Link
HK (1) HK1144102A1 (en)

Similar Documents

Publication Publication Date Title
HK1109406A1 (en) Rnai modulation of apob and uses thereof
EP1718602A4 (en) Therapeutic and carrier molecules
EP1896084A4 (en) Rnai modulation of hif-1 and theraputic uses thereof
EP1993611A4 (en) RNAi MODULATION OF TGF-BETA AND THERAPEUTIC USES THEREOF
EP1744744A4 (en) Bioactive compounds and methods of uses thereof
HRP20140271T1 (en) Human antibodies against rabies and uses thereof
IL178996A0 (en) Thienopyridinone compounds and methods of treatment
EP1909850A4 (en) Rnai modulation of the rho-a gene and uses thereof
EP2069380A4 (en) Rnai modulation of scap and therapeutic uses thereof
IL182436A0 (en) Thienopyridinone compounds and methods of treatment
EP1720888A4 (en) Antimicrobial carbohydrates and methods of using same
EP1906976A4 (en) Therapeutic polymers and methods of use
GB0411861D0 (en) Authentication of applications
EP1942911A4 (en) Therapeutic molecules and their uses
GB0426196D0 (en) Methods of treatment
IL185575A0 (en) Benzoxazocines and their therapeutic use
HK1144102A1 (en) Rnai modulation of rsv and therapeutic uses thereof rsv
GB0408521D0 (en) Treatment of sepsis
EP1841464A4 (en) Rnai modulation of the nogo-l or nogo-r gene and uses thereof
GB0423173D0 (en) Treatment of diabetes
GB201013152D0 (en) Prophylactic and therapeutic agents and uses thereof
ZA200704046B (en) Treatment of burns
HU0400952D0 (en) Treatment of anus-cancer
GB0517027D0 (en) Provision of medicines and treatment
PL365717A1 (en) Forty percent solution of ammonal

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170106